Stockscreener 앱 받기
77.00
2.79%
-2.21
전일 마감가:
$79.21
열려 있는:
$78.42
하루 거래량:
363.77K
Relative Volume:
0.66
시가총액:
$2.94B
수익:
-
순이익/손실:
$-241.60M
주가수익비율:
-11.64
EPS:
-6.6167
순현금흐름:
$-201.34M
1주 성능:
+3.89%
1개월 성능:
+5.28%
6개월 성능:
-0.41%
1년 성능:
+28.85%
1일 변동 폭
$75.01
$79.31
1주일 범위
$71.62
$79.36
52주 변동 폭
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
77.00 | 2.85B | 0 | -241.60M | -201.34M | -6.6167 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 재개 | Stifel | Buy |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-06-11 | 재개 | Raymond James | Strong Buy |
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 개시 | H.C. Wainwright | Buy |
| 2023-05-17 | 개시 | Raymond James | Outperform |
| 2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 개시 | Stifel | Buy |
| 2023-04-20 | 개시 | Morgan Stanley | Overweight |
| 2023-03-23 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - Morningstar
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
TradingKey - TradingKey
Disc Medicine Inc (IRON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Disc Medicine Inc (IRON) Institutional Confidence - TradingKey
Disc Medicine Inc (IRON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRON|Disc Medicine Inc|Price:74.120|Chg%:-1.740 - TradingKey
Disc Medicine Inc (IRON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRON|Disc Medicine Inc|Price:74.640|Chg%:+0.520 - TradingKey
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verra Mobility Corporation Investors with Losses to Secure Counsel Before Important August 4 Deadline in Securities Class Action - GlobeNewswire Inc.
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Price to earnings forward of Disc Medicine, Inc. – NASDAQ:IRON - TradingView
Going Deeper On Disc Medicine (NASDAQ:IRON) - Seeking Alpha
Disc Medicine, Inc. (IRON) Stock Analysis: Biotech Innovator With 36.52% Upside Potential - DirectorsTalk Interviews
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - ACCESS Newswire
(IRON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Truist Securities Initiates Coverage of Disc Medicine (IRON) with Buy Recommendation - MSN
Lobbying Update: $50,000 of DISC MEDICINE lobbying was just disclosed - Quiver Quantitative
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - ACCESS Newswire
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Cantor Fitzgerald reiterates Disc Medicine stock rating on pipeline catalysts - Investing.com
Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing - Moomoo
Disc Medicine CEO John Quisel sells $2.47m in shares By Investing.com - Investing.com India
Form 4 Disc Medicine Inc For: 14 July By Investing.com - Investing.com South Africa
Disc Medicine CEO John Quisel sells $2.47m in shares - Investing.com
Disc Medicine (NASDAQ: IRON) CEO exercises options and sells 33,000 shares - Stock Titan
Form 144 Disc Medicine For: 13 July By Investing.com - Investing.com South Africa
Ironwood Pharmaceuticals (NASDAQ: IRON) plans 33,000-share sale via options exercise - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
Price to earnings forward of Disc Medicine, Inc. – BOATS:IRON - TradingView
Disc Medicine Inc. (IRON) Q1 2026 Earnings: Clinical Progress Amidst Market SkepticismRevenue Inflection Point - dars.gov.et
Disc Medicine COO Jonathan Yu sells $8,250 in stock By Investing.com - Investing.com Nigeria
Form 4 Disc Medicine Inc For: 9 July By Investing.com - Investing.com Canada
Disc Medicine COO Jonathan Yu sells $8,250 in stock - Investing.com
Disc Medicine (IRON) COO trades 100 shares after option exercise under 10b5-1 plan - Stock Titan
Why Disc Medicine's Extended Hercules Credit Access Could Reshape IRON's Funding Flexibility Narrative - simplywall.st
Broker files Form 144 for 10,000 IRON shares (IRON) — option exercise sale - Stock Titan
IRON Q1 2026 Earnings: Narrower-than-expected loss highlights cost control amid clinical progressLong-Term Guidance - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Investors to Connect - The National Law Review
Disc Medicine (IRON) Could Be 67% Undervalued On Its $30 Million Loan Reset - Sahm
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Disc Medicine Inc 주식 (IRON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Quisel John D | Chief Executive Officer |
Jul 13 '26 |
Sale |
74.96 |
33,000 |
2,473,780 |
226,064 |
2.44%
0.02%
자본화:
|
볼륨(24시간):